Advanced search
Publication Cover
Epigenomics Volume 12, 2020 - Issue 8
Submit an article Journal homepage
72
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Epigenetic fragility of the endocannabinoid system under stress: risk for mood disorders and pharmacogenomic implications

Sari Goldstein Ferber1 Psychology Department, Bar-Ilan University, Ramat Gan, Israel;2 Gonda Brain Research Center, Bar-Ilan University, Ramat Gan, IsraelView further author information
,
Tania L Roth3 Department of Psychological & Brain Sciences, University of Delaware, DE 19716, USAView further author information
&
Aron Weller1 Psychology Department, Bar-Ilan University, Ramat Gan, Israel;2 Gonda Brain Research Center, Bar-Ilan University, Ramat Gan, IsraelCorrespondence[email protected]
View further author information
Pages 657-660 | Received 28 Jan 2020, Accepted 19 Feb 2020, Published online: 12 May 2020

References

  • Goldstein Ferber S , TrezzaV , WellerA Early life stress and development of the endocannabinoid system: a bidirectional process in programming future coping. Dev. Psychobiol. doi:10.1002/dev.21944 (2019).
  • Basavarajappa B , NixonR , ArancioO. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration. Mini Rev. Med. Chem.9(4), 448–462 (2009).
  • Monory K , LutzB. The endocannabinoid system as a therapeutic target in epilepsy. In: Cannabinoids and the Brain.Springer, USA, 407–422 (2008).
  • Yadid G , FriedmanA. Dynamics of the dopaminergic system as a key component to the understanding of depression. Prog. Brain Res.172, 265–286 (2008).
  • Ashton CH , MoorePB. Endocannabinoid system dysfunction in mood and related disorders. Acta. Psychiatr. Scand.124(4), 250–261 (2011).
  • Hoehe MR , CaenazzoL , MartinezMMet al. Genetic and physical mapping of the human cannabinoid receptor gene tochromosome 6q14-q15. New Biol!.3, 880–885 (1991).
  • Hillard CJ , WeinlanderKM , StuhrKL. Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience204, 207–229 (2012).
  • Carnevali L , StatelloR , VacondioFet al. Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats. Eur. Neuropsychopharmacol.32, 77–87 (2020).
  • Conradt E , AdkinsDE , CrowellSE , RabyKL , DiamondLM , EllisB. Incorporating epigenetic mechanisms to advance fetal programming theories. Dev. Psychopathol.30(3), 807–824 (2018).
  • Wirz L , ReuterM , FeltenA , SchwabeL. An endocannabinoid receptor polymorphism modulates affective processing under stress. Soc. Cogn. Affect. Neurosci.13, 1177–1189 (2018).
  • Conzelmann A , ReifA , JacobCet al. A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional-motivational reactivity. Psychopharmacology (Berl).224(4), 573–579 (2012).
  • Ruehle S , ReyAA , RemmersF , LutzB. The endocannabinoid system in anxiety, fear memory and habituation. J. Psychopharmacol.26(1), 23–39 (2012).
  • Lazary J Eszlari N Juhasz G Bagdy G .Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma. Eur. Neuropsychopharmacol.26(6), 1020–1028 (2016).
  • Morena M , PatelS , BainsJS , HillMN. Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology41(1), 80–102 (2016).
  • Hill MN , PatelS. Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses. Biol. Mood Anxiety Disord.3(1), 19 (2013).
  • Mota N , SumnerJA , LoweSRet al. The rs1049353 polymorphism in the CNR1 gene interacts with childhood abuse to predict posttraumatic threat symptoms. J. Clin. Psychiatry76(12), e1622–e1623 (2015).
  • Doherty TS , RothTL. Epigenetic landscapes of the adversity-exposed brain. In: Prog. Mol. Biol. Transl. Sci.Elsevier B.V., 1–19 (2018).
  • Franklin TB , RussigH , WeissICet al. Epigenetic transmission of the impact of early stress across generations. Biol. Psychiatry68(5), 408–415 (2010).
  • Domschke K , DannlowskiU , OhrmannPet al. Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression. Eur. Neuropsychopharmacol.18(10), 751–759 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.